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 Differences in DNA methylation are observed at the NR3C1 exon 1F in depression. 
 The degree of DNA methylation at the NR3C1 exon 1F is correlated with increases in 
morning cortisol concentrations and childhood emotional abuse severity. 
















DNA methylation differences at the glucocorticoid receptor gene in depression are related to functional 
alterations in hypothalamic-pituitary-adrenal axis activity and to early life emotional abuse 
Authors: Chloё Farrell1, Kelly Doolin1, Niamh O’ Leary1, Chaitra Jairaj1, Darren Roddy1, Leonardo Tozzi2, 
Derek Morris3, Andrew Harkin4, Thomas Frodl2, Zsófia Nemoda5, Moshe Szyf6, Linda Booij7,8 and Veronica 
O’Keane1,9. 
1Department of Psychiatry, School of Medicine, Trinity College Institute of Neuroscience, Trinity College 
Dublin, Dublin 2, Ireland 
2Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Magdeburg, 
Germany 
3Discipline of Biochemistry, NUI Galway, Galway, Ireland 
4School of Pharmacy and Pharmaceutical Studies, Trinity College Institute of Neuroscience, Trinity College 
Dublin, Dublin 2, Ireland 
5Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, 
Budapest, Hungary 
6Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada 
7Department of Psychology, Concordia University, Montreal, Quebec, Canada 
8Sainte-Justine Hospital Research Centre, Montreal, Quebec, Canada 
9Trinity Centre for Health Sciences, AMNCH (Tallaght Hospital), Tallaght, Dublin 24, Ireland 
Corresponding author: Chloё Farrell, Ph.D 
Trinity College Institute of Neuroscience 
The Lloyd Institute, Room 336 
Trinity College Dublin, Dublin 2, Ireland 
Phone: +353 1 896 4234  
Email: farrelc6@tcd.ie  
Key Words: Epigenetics; depression; early life adversity; hypothalamic-pituitary-adrenal 

















Depression is associated with alterations in hypothalamic-pituitary-adrenal (HPA) axis activity. A 
proposed mechanism to explain these alterations are changes in DNA methylation levels, secondary to 
early life adversity (ELA), at stress-related genes. Two gene regions that have been implicated in the 
literature, the glucocorticoid receptor gene (NR3C1) exon 1F and the FKBP5 gene intron 7 were examined 
in 67 individuals (33 depressed patients and 34 controls). We investigated whether cortisol 
concentrations, evaluated in 25 depressed patients and 20 controls, and measures of ELA were 
associated with the degree of methylation at these candidate gene regions. Mean NR3C1 exon 1F DNA 
methylation levels were significantly increased in the depressed cohort and the degree of methylation 
was found to be positively associated with morning cortisol concentrations. DNA methylation levels at 
specific CG sites within the NR3C1 exon 1F were related to childhood emotional abuse severity. DNA 
methylation at CG38 was related to both HPA axis and childhood emotional abuse measures in the 
depressed group. No FKBP5 differences were revealed. Our findings suggest that hypermethylation at the 
NR3C1 exon 1F may occur in depression. This locus-specific epigenetic change is associated with higher 




























Major depressive disorder (MDD) is a debilitating mood disorder with a lifetime prevalence rate of 
approximately 17% (Kessler et al., 2005). Despite extensive research, there are no established biological 
markers for the diagnosis of depression (Mossner et al., 2007). Longitudinal studies indicate that many 
adulthood-onset diseases are associated with adverse developmental or biological events experienced 
early in life. The latency between exposure to adversity and development of a disorder can span years, 
and even decades in some instances (Shonkoff et al., 2009). Exposure to early life adversity (ELA) has 
been identified as a major risk factor in the development of almost all psychiatric disorders (Kessler et al., 
2010), including MDD (Kessler and Magee, 1993). It has been reported that adult patients with MDD have 
a two-fold higher rate of ELA compared to healthy controls and that ELA has been shown to predict 
earlier-onset depression, a higher risk of recurrent depression, more severe course of illness, greater 
chronicity and suicide (Williams et al., 2016). MDD patients with a history of ELA show different 
treatment responses reinforcing the idea of diverse pathways to the loose clinical syndrome of 
depression, one of which is ELA (Nemeroff et al., 2003). 
The hypothalamic-pituitary-adrenal (HPA) axis is the main stress response system (Bellavance and Rivest, 
2014). Through glucocorticoid receptors (GR) cortisol mediates a myriad of tissue-specific effects (Young 
et al., 2003).  Importantly, cortisol signaling via GR is responsible for negative feedback inhibition of the 
HPA axis.  A frequently replicated finding in depression research is the association of depression with 
hyperactivity of the HPA axis (Pariante and Lightman, 2008). It has been hypothesized that the increased 
HPA axis activity results from dysfunctional feedback because of reduced efficacy of central GR function 
(Young et al., 2003). The cortisol awakening response (CAR), the brisk increase of cortisol levels within 20-
30 minutes of awakening in the morning (Fries et al., 2009), provides a naturalistic test for a cortisol 
stress response. Several studies have demonstrated an increased CAR in currently depressed individuals 
(Suzuki et al., 2013; Vreeburg et al., 2009), as well as in recovered patients with depression (Bhagwagar 
et al., 2003). 
The GR co-chaperone protein FK506 binding protein 5 (FKBP5) is an immunophillin protein that 
accompanies the inactive GR complex in the cytoplasm. FKBP5 reduces the affinity of the GR complex for 















within the FKBP5 gene may influence individuals’ susceptibility to depression, with certain variants 
associated with increased FKBP5 protein levels (Szczepankiewicz et al., 2014), and consequently with 
relative decrease in GR complex activity. A recent meta-analysis supports the association between 
specific FKBP5 genetic variants and an increased risk of depression (Rao et al., 2016). 
Epigenetic mechanisms are essential for the regulation of gene expression as they can modulate events 
at the level of transcription and translation (Portela and Esteller, 2010). Epigenetic mechanisms may 
provide an etiological link between ELA and the syndrome of depression (Dalton et al., 2014). The 
addition of a methyl group to the cytosine within a CG site in a critical regulatory region can inhibit 
transcriptional activity (Farrell and O’Keane, 2016).  
In relation to MDD and alterations in HPA axis activity, an interesting epigenetic modification is 
methylation of a nerve growth factor-inducible protein A (NGFI-A) binding site located in exon 1F of the 
GR gene, the nuclear receptor subfamily 3 group C member 1 (NR3C1) (Swirnoff and Milbrandt, 1995), 
that is associated with ELA. Alterations at or near this NGFI-A binding site may explain one of the 
biological links between ELA and the development of depressive illnesses (Smart et al., 2015). NR3C1 
exon 1F hypermethylation in relation to ELA has been demonstrated in peripheral tissues, including cord 
blood, white blood cells and whole blood (Oberlander et al., 2008; Perroud et al., 2011; Radtke et al., 
2011; Radtke et al., 2015) and would potentially result in dysregulation of HPA axis negative feedback 
were it occurring in the brain. It is possible that this hypermethylation is indeed occurring centrally as 
increased DNA methylation has been reported in the hippocampus of the orthologue 17 site in stressed 
rats (Weaver et al., 2004) and in the hippocampus of abuse victims who died by suicide (McGowan et al., 
2009). 
FKBP5 has recently attracted attention as a protein possibly implicated in the area of epigenetic-
mediated gene-childhood trauma interaction leading to adult mental illness. Klengel et al. performed the 
first human study examining gene-ELA interaction and methylation at FKBP5. They showed that 
individuals suffering from post-traumatic stress disorder (PTSD) who were exposed to ELA and who 
carried a functional FKBP5 risk T allele at rs1360780 had decreased levels of methylation at intron 7 of 















activation, leading to symptoms of GR resistance (Klengel et al., 2013). One study examining FKBP5 
methylation in individuals with the risk T allele and remitted depression revealed a (non-significant) trend 
towards higher methylation levels compared to healthy controls (Höhne et al., 2015). There are a few 
more studies that examined FKBP5 methylation association to ELA but the direction of effect was 
inconsistent (Needham et al., 2015; Tyrka et al., 2015). 
No studies, to our knowledge, have examined NR3C1 and FKBP5 methylation in the same individuals, and 
the possible associations between their DNA methylation levels and HPA axis function. The aims of this 
study were to determine if DNA methylation at the NR3C1 exon 1F and/or FKBP5 intron 7 were altered in 
individuals with depression compared to controls. We also explore possible relationships between NR3C1 


































METHODS AND MATERIALS 
Patient Recruitment and Assessment 
Depressed patients were recruited from the Tallaght Mental Health Services. Any patient presenting with 
depression was considered for the study. They were screened for eligibility by a consultant psychiatrist. 
Screening involved assessing whether patients fulfilled criteria for a Major Depressive Episode (MDE) 
from the Mini International Neuropsychiatric Interview (M.I.N.I) (Sheehan et al., 1997); scored >17 on the 
Hamilton Depression Rating 21-Item Scale (HAM-D-21) (Hamilton, 1960), indicative of moderate 
depression; were not suffering from a psychotic or substance abuse disorder or from any chronic medical 
illnesses and were not taking any steroid medications, excluding the contraceptive pill. Healthy, control 
individuals were screened and recruited from the general population. Screening involved establishing 
that individuals had never experienced a mental health disorder, scored ≤7 on the HAM-D-21, were not 
suffering from any chronic medical illnesses, and were not taking any steroid medications, except the oral 
contraceptive pill. For both groups, 45 years, considered the beginning of middle age (Stevenson, 2010), 
was selected as the maximum age for inclusion to reduce the possibility of age-related effects on 
biological data. The groups were balanced for age and sex. If individuals met inclusion and exclusion 
criteria, they were invited to participate. If, following a thorough explanation of the study, and they 
remained willing to participate, they gave written informed consent. As this was not an intervention 
study, all treatment was continued as usual. Detailed demographic information was collected. The 
International Standard Classification of Education (ISCED) is a standardized scale used to gather 
information on educational achievement (UNESCO, 2011) and was used to grade participants’ level of 
education. Participants were then administered a battery of clinical instruments: Centre for 
Epidemiological Studies Depression Rating Scale (CES-D) (Orme et al., 1986), suicidality module (Module 
C) of the M.I.N.I (Sheehan et al., 1997) and the Childhood Trauma Questionnaire (CTQ) (Bernstein, et al., 
1997). The CTQ is a retrospective, self-report measure of ELA. The CTQ contains five subscales; three 
assessing abuse (emotional, physical and sexual) and two assessing neglect (emotional and physical). 















assessed. The study was approved by the Tallaght Hospital/St. James’s Hospital Joint Research Ethics 
Committee (2013/23/02) following the principles in the 1964 Declaration of Helsinki(World Medical 
Association, 2013).  
 
DNA methylation analysis of HPA axis genes 
DNA methylation of the NR3C1 exon 1F and FKBP5 intron 7 was measured in whole blood by 
pyrosequencing, performed on bisulfite-treated DNA. A schematic representation of both regions 
investigated can be found at Figure S1. Blood was collected into PAXgene® Blood DNA tubes and DNA 
was extracted using the FlexiGene® DNA Kit (Qiagen, Valencia, California) using the manufacturer’s 
recommended protocol. 1 μg DNA was bisulfite-treated using the EZ DNA Methylation Gold™ Kit (Zymo 
Research, Irvine, California) using the manufacturer’s recommended protocol. A 319bp fragment 
corresponding to our region of interest within the NR3C1 exon 1F was amplified by touchdown PCR using 
the following primers: NR3C1F-FW-biotin: 5Biosg/GTTTTTAATTTTTTAGGAAAAAGGGT and NR3C1F-REV: 
ACCCCTTTCCAAATAACACACTTC. A 341bp fragment corresponding to our region of interest within the 
FKBP5 intron 7 was amplified by standard PCR using the following primers: FKBP5-FW: 
TGGGATAATAATTTGGAGTTATAGTGTAGG and FKBP5-REV-biotin: 
5Biosg/AAATTTATCTCTTACCTCCAACACTAC. For both PCR reactions, a master mix solution was made up 
using EpiMark® Hot Start Taq DNA Polymerase (NEB® Inc., Ontario, Canada). A no template control was 
included to monitor contamination of extraneous nucleic acids. The pyrosequencing reaction was 
performed using the PyroMark Q96 platform (Qiagen, Valencia, California). Sequencing primers used 
were as follows: NR3C1F_LR_S3: AACTCCCCAATAAATCTAAAAC (NR3C1 exon 1F CG36-CG39), 
NR3C1F_LR_S4: AAAAAACTCCATAACCCTCT (NR3C1 exon 1F CG41) and FKBP5_S4: 
GTTGATATATAGGAATAAAATAAGA (FKBP5 intron 7 CG6-CG7). Percentage methylation levels and quality 



















FKBP5 rs1360780 genotyping 
The rs1360780 allele was genotyped from whole blood DNA using a Taqman SNP Genotyping Assay 
performed on a 7900HT Sequence Detection System (Applied Biosystems, Foster City, California) as 
previously described (Tozzi et al., 2016).  
 
Salivary cortisol analysis 
Saliva samples were collected within one week of recruitment into the study. Participants were 
instructed not to eat, drink or brush their teeth 30 minutes prior to saliva collection. Saliva samples were 
collected in Salivette® tubes (Sarstedt, Nümbrecht, Germany) at five time points throughout the day. 
These time points were 0, 30 and 60 minutes after waking (to assess CAR), and 12 and 12.5 hours after 
waking (to assess diurnal variation). Cortisol concentrations were measured by liquid chromatography-
tandem mass spectrometry (LC-MS/MS) as previously described (Jones et al., 2012).  
 
Statistical Analysis 
Data are presented as mean with standard deviation (SD) or standard error of the mean (SEM) where 
appropriate. All data were tested for normality using the Shapiro-Wilk test. DNA methylation and cortisol 
values were log transformed to normalize distribution. DNA methylation and cortisol data were analyzed 
using analyses of variance with covariates where appropriate. In our preliminary analysis it was observed 
that smoking and education were driving differences in DNA methylation between the two groups, and 
were therefore included as covariates in the final analysis. Similarly, in the preliminary cortisol analysis, it 
was observed that BMI and education were driving differences between the two groups, and therefore 
were included as covariates in the final analysis. Non-parametric data were analyzed using the Mann-
Whitney U test. Associations between categorical variables were tested using the Chi-Square (χ2) test. 
Correlational analysis was carried out using Spearman’s rho statistics. Given the exploratory nature of the 
correlational analyses, Bonferroni corrections were not applied due to the heightened risk of Type II 















Graphs were generated using GraphPad Prism Software Version 6.00 (La Jolla, California). All data were 









































Demographic and clinical data of patients with depression and healthy controls 
There were no significant differences in age, gender or BMI between the groups. The depressed group 
had a higher prevalence of smokers (p=0.02) and lower duration of education (p<0.001), compared to 
that of the control group. Consistent with a diagnosis of depression, patients with MDD had significantly 
higher HAM-D-21 and CES-D scores compared to healthy controls. A score of 19-22 in the HAM-D-21 is 
considered to represent severe depression. The mean HAM-D score in the patient group was 21.94 
(SD=5.49) indicating that overall this group was severely depressed. Furthermore, a score of 9-16 in the 
suicidality module of the M.I.N.I indicated that there was a moderate suicide risk. The mean score in the 
patient group was 10.06 (SD=12.16), thus indicating a moderate risk for a suicide. Any participant who 
met criteria for “moderate” severity on any of the CTQ subscales was considered to have experienced 
ELA. The depressed group had a higher prevalence of individuals who had ELA, and had significantly 
higher CTQ global, emotional abuse, physical abuse, emotional neglect and physical neglect compared to 
the control group. Within the depressed sample, 20 individuals were receiving pharmacological 
treatment for depression at the time of recruitment. Of these, 14 were taking selective serotonin 
reuptake inhibitors (SSRIs), two were taking serotonin-noradrenaline reuptake inhibitors (SNRIs) and four 
were receiving other antidepressant treatments [Table 1]. 
 
DNA methylation levels of NR3C1 exon 1F in depressed patients and healthy controls 
Mean DNA methylation at NR3C1 exon 1F was significantly higher in the depressed patients relative to 
healthy controls (F=3.89, d=0.49, p=0.05). There were no significant differences in DNA methylation at 
any of the individual CG sites measured [Table 2].   
 
DNA methylation levels of FKBP5 intron 7 promoter in depressed patients and healthy controls 
There were no statistically significant differences in overall, or individual CG site, DNA methylation at 
FKBP5 intron 7 in depressed patients relative to healthy controls [Table 2]. At the analysis of rs1360780 















depressed group, 16 possessed the CC genotype and 17 possessed the CT/TT genotype. In the control 
group, 21 possessed the CC genotype and 13 possessed the CT/TT genotype. There was no significant 
difference in the prevalence of the risk allele between the groups. There were no significant differences 
in methylation when individuals were divided based on their FKBP5 rs1360780 allele status [Table 3]. 
 
Salivary cortisol levels in depressed patients and healthy controls 
Out of the 67 participants recruited into the study with DNA methylation data available, 45 (25 depressed 
patients and 20 healthy controls) had corresponding cortisol data [Table S1]. Twenty-four participants 
provided insufficient sample quantity or quality, and were excluded from the analysis. Analysis revealed a 
significant increase in wakening (T0) cortisol concentrations and overall morning cortisol output in 
depressed patients compared to healthy controls. There were no differences in evening cortisol values 
between the groups [Table 4]. 
 
Associations between cortisol concentrations and NR3C1 DNA methylation 
There was a significant relationship between methylation at the NR3C1 exon 1F CG38 site and cortisol 
levels at T0, and with average morning cortisol output [Table 5].  
 
Associations between ELA and NR3C1 DNA methylation 
Spearman’s rho correlation analysis revealed a significant positive association between the severity of 
emotional abuse experienced during childhood and the degree of DNA methylation at NR3C1 exon 1F 
CG37 (r=0.53, p=0.01) and CG38 (r=0.43, p=0.04) [Figure 2]. This finding was only present in depressed 
individuals who reported ELA and not in the overall sample. No associations were revealed between 
NR3C1 DNA methylation and physical/sexual abuse or emotional/physical neglect. No associations were 



















This study sought to determine whether there were differences in DNA methylation levels at the NR3C1 
exon 1F and/or the FKBP5 intron 7 were present in a sample of depressed individuals, and if so, whether 
these differences were associated with changes in HPA axis measures, as measured by the CAR/diurnal 
cortisol-HPA axis test. The overall percentage of methylation at the NR3C1 exon 1F region was 
significantly increased in the depressed patients relative to healthy controls. The degree of this 
methylation was related to increased cortisol concentrations at T0, as well as overall morning cortisol 
secretion in the entire study cohort. Within the NR3C1 exon 1F, DNA methylation levels at CG38 were 
related to the same two cortisol measures. CG38 DNA methylation was also related to childhood 
emotional abuse severity in the depressed group. No significant differences between depressed and 
control groups, in the total group and when stratifying for a risk polymorphism, were seen in FKBP5 DNA 
methylation measures.  
 
NR3C1 DNA methylation and the HPA axis 
Although NR3C1 DNA methylation levels were low in general, the overall percentage methylation at the 
NR3C1 exon 1F region was significantly increased in the depressed patients relative to healthy controls. 
This finding is in keeping with the literature generally (Palma-Gudiel et al., 2015), with the same exon 1F 
region being previously implicated in various stress-related psychopathologies including depression, 
bipolar disorder and PTSD (Argentieri et al., 2017). The mechanism(s) underlying how ELA produces 
targeted methylation of specific gene regions is currently unknown. We know that the epigenome is 
responsive to external influences and it has been hypothesized that this plasticity enables optimal 
adaptation to changing environmental conditions (Ryan et al., 2016). It is possible that this plasticity gives 
trauma the opportunity to impact the epigenome in a manner that explains the long-term effects of 
trauma on the risk of developing psychiatric disorders. Future studies should attempt to elucidate the 
molecular mechanisms underlying trauma-induced DNA methylation changes at specific gene regions. 
The depressed group had increased cortisol concentrations upon wakening, as well as an overall increase 















consistent (Gunnar and Vazquez, 2001), elevated wakening cortisol levels have often been found in a 
significant number of previous studies examining the CAR tests in depression (Bhagwagar et al., 2005; 
Suzuki et al., 2013;,Vreeburg et al., 2009). While there were no significant methylation differences 
between the depressed and control groups at individual NR3C1 exon 1F CG sites, significant relationships 
were revealed between individual CG sites and CAR parameters, particularly at the CG38 site. 
Interestingly, the relationship between methylation at the CG38 site and the CAR measures existed for 
the two CAR values that distinguished the depressed from the control group (i.e. T0 and morning 
average). It is worth highlighting that CG37 and CCG38 are at the location of the NGFI-A binding site 
(Palma-Gudiel et al., 2015) that has been previously associated with depression pathophysiology(Smart et 
al., 2015). This indicates a possible functional relationship between DNA methylation alterations at CG38 
of the NR3C1 exon 1F and HPA axis activity. 
 
NR3C1 methylation and ELA 
As previously mentioned, ELA has been identified as a major risk factor in the development of almost all 
psychiatric disorders (Kessler et al., 2010), including MDD (Kessler and Magee, 1993). To date, a number 
of studies have shown that increases in DNA methylation at the glucocorticoid receptor gene have been 
associated with exposure to childhood abuse (McGowan et al., 2009; Perroud et al., 2011; Radtke et al., 
2015). Overall, these studies have revealed positive associations with the degree of methylation at the 
exon 1F region and the severity of abuse exposure during childhood. In our study, we observed a 
significant positive association between the severity of emotional abuse experienced during childhood 
and the degree of DNA methylation at NR3C1 exon 1F CG37 and CG38 sites. This finding is particularly 
noteworthy as a diagnosis of depression is more likely to be related to reports of childhood emotional 
abuse than to physical or sexual abuse (Gibb et al., 2007). This finding was only present in depressed 
patients who reported ELA and was not present in the overall cohort, suggesting an association between 
ELA severity, rather than depression per se, and methylation status of the CG37 and CG38 sites NR3C1 
exon 1F. As previously mentioned, the CG37 and CG38 sites are at the NGFI-A binding site, which has 















findings of our present study solidifies these previous finding. Overall, although causality cannot be 
determined, the NR3C1 methylation findings in this group of depressed patients suggests that the CG38 
site of exon 1F is methylated in association with emotional abuse in childhood and that this may lead to 
increased morning HPA axis activity. 
 
FKBP5 intron 7 DNA methylation in depression 
As FKBP5 intron 7 methylation alterations have previously been observed in individuals with a history of 
ELA who suffer with post-traumatic stress disorder (PTSD) (Klengel et al., 2013), we sought to assess 
differences in methylation at the same region in our depressed cohort. Analysis revealed no significant 
differences in DNA methylation at FKBP5 intron 7 in depressed patients relative to healthy controls. As 
the previous methylation findings have been allele-specific in nature, the functional FKBP5 SNP 
rs1360780 was genotyped and groups were divided according to whether or not they possessed the risk 
T-allele. This allele is associated with increased FKBP5 induction by glucocorticoids (Fujii et al., 2014). In 
our cohort, no significant allele-specific differences in DNA methylation were observed in depressed 
patients relative to healthy controls; nor did the risk-allele status separate out depressed from control 
groups. No associations between FKBP5 methylation and cortisol concentrations or CAR parameters were 
observed. Overall, this study did not reveal significant differences in FKBP5 intron 7 methylation in 
depressed individuals and healthy controls, even when considering the presence of a risk polymorphism. 
These findings suggest that although FKBP5 DNA methylation is implicated in certain stress-related 
disorders, it may not be a candidate marker for state depression. 
 
Study limitations and strengths 
A limitation of this study is its cross-sectional design. Findings from cross-sectional studies need to be 
interpreted with caution as it cannot be assumed that model parameters are stable over time (Bowen 
and Wiersema, 1999). There is extensive evidence that the depressive phenotype changes over the 
course of an illness (O’Keane et al., 2012), therefore, future longitudinal studies are necessary to solidify 















statistical power is limited because of the relatively small sample size. Three saliva samples were 
collected in the morning to assess individual CAR measurements. We found that subjects were less likely 
to comply if more than three samples were required. Three samples are deemed to be adequate for the 
assessment of the CAR (Stalder et al., 2016), but additional morning samples can provide a better 
overview of HPA axis activity.  Furthermore, due to lapses in participant compliance, not all participants 
had cortisol concentration values. This needs to be considered when interpreting the results of 
correlation analyses. The study’s relatively small sample size needs to be highlighted as a limitation in the 
context of statistical power. Underpowered statistical analyses run the risk of Type II errors (i.e. false 
negative results) and this should be considered when interpreting the results presented in this 
manuscript. Additionally, given the novelty of DNA methylation analysis in psychiatry research, much of 
the work presented is exploratory in nature. As a result of this exploratory work, no corrections were 
made to address multiple comparisons, which run the risk of Type I errors (i.e. false positive results). This 
should be considered when interpreting the results. Future work should attempt to (i) increase sample 
size to increase statistical power, and (ii) use conservative post-hoc corrections (i.e. Bonferroni) to ensure 
the reporting of robust, statistically significant, positive findings. We did not include antidepressant use 
as a covariate in our analyses as they did not impact upon the DNA methylation or cortisol results across 
the groups. This could be due to of the relatively small sample size, and needs to be considered when 
interpreting the findings. Finally, this study would have benefited from the inclusion of a higher number 
of individuals exposed to early life adversity. Future studies should attempt to increase the number of 
non-depressed controls who have been exposed to early life adversity, in an attempt to disentangle the 
effects of early life adversity in the pathogenesis of depression. 
 This study had a number of strengths. To our knowledge, this is the first study to assess both NR3C1 and 
FKBP5 DNA methylation in the same sample and to examine this methylation in relation to HPA axis 
activity and ELA in clinically depressed and healthy samples. Another strength of the study is the use of 
LC-MS/MS for quantification of cortisol concentrations. More commonly used immunoassays are less 
specific and measure the inactive metabolite cortisone, resulting in false-high cortisol levels being 















salivary cortisol (Antonelli et al., 2015). A final strength of the study is the use of whole blood samples. 
Whole blood is easily accessible in the clinical environment, and may be potentially useful in the future 
for diagnosis and prognosis of depression. The use of whole blood should also be considered as a 
limitation as it is known that DNA methylation patterns differ across tissues (Kriebel et al., 2016), and this 
should be considered when interpreting the findings presented in this manuscript. 
 
Conclusion 
While there were no differences in DNA methylation levels at the FKBP5 sites of interest, methylation at 
the NR3C1 exon 1F region was significantly increased in the depressed group. Our findings of increases in 
morning cortisol concentrations, in a group with MDD compared to controls, are compatible with overall 
findings of HPA axis hyperactivity in individuals suffering with MDD. This study provides evidence that this 
hyperactivity is associated with increased methylation at the NR3C1 exon 1F, within which the CG38 was 
identified as being particularly associated with CAR over-activity. The degree of methylation at CG38 was 
also specifically associated with childhood emotional abuse severity in depressed patients. The CG38 site 
resides at a NGFI-A site that has been previously investigated in relation to HPA axis alterations in 
depression. These results suggest that epigenetic alterations at the NR3C1 gene, but not the FKBP5 gene, 
may contribute to the finding of both increased morning cortisol levels in depression and ELA. The study 
provides novel insights into the molecular basis of depression and how this may evolve from ELA.  
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Tables and Figures 
Table 1. Demographic and clinical data for all recruited depressed patients and healthy controls 
   Patients (n=33)  Controls (n=34)  Statistics (p-value) 
Age (years)  28.27 (8.77)  28.21 (7.47)  Z=-0.08, p=0.94 
Gender (M/F)  9/24   13/21   χ2=0.91, p=0.44 
BMI   26.31 (6.89)  23.15 (3.87)  Z=-1.65, p=0.10 
Smoking (Y/N)  12/21   4/30   χ2=5.58, p=0.02* 
ISCED Education  3.12 (1.58)  6.00 (1.97)  Z=-4.85, p<0.001*** 
HAM-D-21  21.94 (5.49)  2.16 (2.93)  Z=-6.88, p<0.001*** 
CES-D   38.39 (9.54)  6.82 (8.77)  Z=-6.53, p<0.001*** 
CTQ Global Score 42.30 (15.31)  29.35 (7.81)  Z=-4.01, p<0.001*** 
CTQ EA   10.25 (4.28)  6.15 (2.22)  Z=-4.39, p<0.001*** 
CTQ PA   6.88 (2.98)  5.50 (1.33)  Z=-2.41, p=0.02* 
CTQ SA   7.47 (6.26)  5.53 (3.09)  Z=-1.27, p=0.20 
CTQ EN   11.06 (5.14)  6.74 (2.21)  Z=-3.35, p=0.001*** 
CTQ PN   7.03 (2.72)  5.50 (1.58)  Z=-2.81, p=0.004** 
ELA (Y/N)  15/18   3/31   χ2=11.44, p=0.001*** 
Suicidality  10.06 (12.16)  0.00 (0.00)  Z=-5.86, p<0.001*** 
Data expressed as mean with SD in parentheses. Statistical analysis was performed using a Mann 
Whitney U test (Age, BMI, Education, HAM-D, CES-D, PSQI, CTQ Global Score, Suicidality) and Chi squared 
(χ2) test (Gender, Smoking, ELA, Antidepressant use). BMI=Body Mass Index; ISCED=International 















Epidemiologic Studies Depression Scale; CTQ=Childhood Trauma Questionnaire; EA=Emotional Abuse; 
PA=Physical Abuse; SA=Sexual Abuse; EN=Emotional Neglect; PN=Physical Neglect. *p≤0.05, **p≤0.01, 
***p≤0.001 vs. control. 
 
Table 2. NR3C1 exon 1F and FKBP5 intron 7 methylation data for depressed patients and healthy 
controls 
   Patients (n=33)  Controls (n=34)  Statistics (p-value) 
Mean NR3C1F*  4.07 (0.57)  3.81 (0.48)  F=3.89, d=0.49, p=0.05 
NR3C1F CG36  2.72 (1.24)  2.44 (1.00)  F=1.80, d=0.25, p=0.19 
NR3C1F CG37  3.12 (1.02)  3.27 (1.23)  F=0.02, d=0.13, p=0.90 
NR3C1F CG38  5.58 (0.94)  5.49 (0.93)  F=0.11, d=0.10, p=0.75 
NR3C1F CG39  5.38 (0.76)  5.27 (0.77)  F=0.84, d=0.14, p=0.36 
NR3C1F CG41  3.57 (1.74)  2.92 (0.95)  F=3.07, d=0.46, p=0.09 
Mean FKBP5  60.11 (4.50)  60.03 (6.09)  F=0.28, d=0.02, p=0.60 
FKBP5 CG6  60.35 (11.57)  62.32 (5.24)  F=0.10, d=0.22, p=0.92 
FKBP5 CG7  57.99 (5.43)  57.74 (8.64)  F=0.34, d=0.04, p=0.57 
Data are expressed as mean whole blood DNA methylation percentage with SD in parentheses. Statistical 
analysis was performed using analysis of variance, with smoking and education as covariates, on log 

















Table 3. FKBP5 intron 7 methylation data for depressed patients and healthy controls, categorized on their rs1360780 allele status 
  Patients CC (n=16) Patients CT/TT (n=17) Controls CC (n=21)          Controls CT/TT (n=13) Statistics (p-value)  
Mean FKBP5 60.88 (3.89)  59.40 (5.25)         60.82 (6.99)        58.90 (4.52)  F=0.79, p=0.51 
FKBP5 CG6 58.61 (16.72)  61.57 (4.30)        62.82 (5.62)                61.61 (4.76)  F=0.31, p=0.82 
FKBP5 CG7 58.97 (4.13)  57.24 (6.67)         58.83 (10.51)              56.18 (4.86)  F=0.85, p=0.47 
Data are expressed as mean methylation percentage with SD in parentheses. Statistical analysis was performed using analysis of variance, with smoking and 
















Table 4. Morning and evening cortisol concentrations in depressed patients and healthy controls 
   Patients (n=25)  Controls (n=20)  Statistics (p-value) 
CAR 
Cortisol T0*  10.88 (6.42)  7.01 (3.98)  F=4.60, d=0.72, p=0.04 
Cortisol T30  13.86 (7.27)  10.07 (4.87)  F=2.75, d=0.61, p=0.11 
Cortisol T60  8.59 (5.70)  7.65 (4.38)  F=0.53, d=0.18, p=0.47 
Cortisol AUCi  100.94 (266.61)  101.67 (245.08)  F=0.72, d=0.01, p=0.40 
 
Cortisol AM average* 11.41 (5.97)  8.54 (3.47)  F=3.96, d=0.59, p=0.05 
Evening cortisol 
Cortisol T720  2.15 (1.99)  3.00 (4.89)  F=0.05, d=0.23, p=0.83 
Cortisol T750  2.48 (2.49)  3.48 (5.36)  F=1.13, d=0.24, p=0.30  
 
Cortisol PM average 2.05 (1.63)  3.13 (4.83)  F=0.18, d=0.30, p=0.68 
Data are expressed as mean cortisol concentrations (nMol/L) with SD in parentheses. Statistical analysis 
was performed using analysis of variance, with BMI and education as covariates on log transformed data. 



















Table 5. Correlational analysis of NR3C1 exon 1F DNA methylation and cortisol concentrations in all participants. 
  NR3C1F CG36  NR3C1F CG37  NR3C1F CG38  NR3C1F CG39  NR3C1F CG41  meanNR3C1F 
Cortisol T0 r=0.29 (p=0.07)  r=0.18 (p=0.26)  r=0.32 (p=0.04)*  r=-0.13 (p=0.47)  r=-0.06 (p=0.73)  r=0.25 (p=0.12) 
Cortisol AM r=0.34 (p=0.03)*  r=0.16 (p=0.32)  r=0.37 (p=0.02)*  r=-0.02 (p=0.90)  r=0.03 (p=0.88)  r=0.31 (p=0.04)* 
















Figure 1. Morning and evening cortisol concentrations in depressed patients and healthy controls. Cortisol concentrations at three morning and two evening time 
points in depressed patients and healthy controls. Data are expressed as mean cortisol concentrations (nMol/L) with SEM, analysis of variance, with BMI and 
















Figure 2. Relationship between NR3C1 exon 1F DNA methylation and early life severity. A significant 
relationship exists between (a) NR3C1 exon 1F CG37 DNA methylation and emotional abuse and (b) 
NR3C1 exon 1F CG38 DNA methylation and emotional abuse. 
 
